Ferrocene incorporated PAMAM dendrons: Synthesis, characterization, and anti-cancer activity against AGS cell line

Medicinal Chemistry Research

Volumn 22, Issue 10, 2013, Pages 4867-4876

  Saǧir, Tuǧba ^a   Işik, Sevim ^a   Şenel, Mehmet ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Anti cancer activity; Ferrocene; PAMAM dendron; Real time cell analysis

Indexed keywords

ACRYLIC ACID METHYL ESTER; ETHYLENEDIAMINE; FERROCENE; FERROCENE POLYAMIDOAMINE; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MICHAEL ADDITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84883452256     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0491-x     Document Type: Article

References (33)

1. Astruc D (2012) Electron-transfer processes in dendrimers and their implication in biology, catalysis, sensing, and nanotechnology. Nat Chem 4(4):255-267
2. Bielawski K, Bielawska A et al (2011) Cytotoxic activity of 3 PAMAM-NH(2) dendrimer-chlorambucil conjugate in human breast cancer cells. Environ Toxicol Pharmacol 32(3):364-372
3. Borowska K, Laskowska B et al (2010) PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal diffusion of the guest. Int J Pharm 398(1-2):185-189
4. Buckley ST, Fischer SM et al (2012) In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives. Eur J Pharm Sci 45(3):235-250
5. Chang Y, Meng X et al (2011) Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). J Colloid Interface Sci 363(1):403-409
6. Chaubey A, Malhotra BD (2002) Mediated biosensors. Biosens Bioelectron 17(6-7):441-456
7. Cheng Y, Li M et al (2008) Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. Eur J Med Chem 43(8):1791-1795
8. Cortez-Maya S, Hernandez-Ortega S et al (2012) Synthesis of 5-aryl-1,4-benzodiazepine derivatives attached in resorcinaren-PAMAM dendrimers and their anti-cancer activity. Bioorg Med Chem 20(1):415-421
9. Gao LM, Hernandez R et al (2009) Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives. Met Based Drugs 2009:420784
10. Gomez Arrayas R, Adrio J et al (2006) Recent applications of chiral ferrocene ligands in asymmetric catalysis. Angew Chem Int Ed Engl 45(46):7674-7715
11. Gu L, Wu ZH et al. (2012) Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Pharm Dev Technol. doi: 10.3109/10837450.2011.653822
12. Hillard EA, Pigeon P et al (2007) The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif. Dalton Trans 21(43): 5073-5081
13. Hillard E, Vessières A et al. (2010) Ferrocene Functionalized Endocrine Modulators as Anticancer Agents. Medicinal Organometallic Chemistry. G. Jaouen and N. Metzler-Nolte, Springer Berlin Heidelberg. 32: 81-117
14. Hughey JR, Keen JM et al (2011) Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of kinetisol(R) dispersing. Int J Pharm 419(1-2):222-230
15. IşIk S, Karagöz A et al (2012) Proliferative and apoptotic effects of olive extracts on cell lines and healthy human cells. Food Chem 134(1):29-36
16. Kopf-Maier P, Kopf H et al (1984) Ferricenium complexes: a new type of water-soluble antitumor agent. J Cancer Res Clin Oncol 108(3):336-340
17. Kovjazin R, Eldar T et al (2003) Ferrocene-induced lymphocyte activation and anti-tumor activity is mediated by redox-sensitive signaling. FASEB J 17(3):467-469
18. Ma M, Cheng Y et al (2007) Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur J Med Chem 42(1):93-98
19. Maddaford SP (2012) A medicinal chemistry perspective on structure-based drug design and development. Methods Mol Biol 841:351-381
20. Martic S, Labib M et al (2011) Ferrocene-peptido conjugates: from synthesis to sensory applications. Dalton Trans 40(28):7264-7290
21. Milhem OM, Myles C et al (2000) Polyamidoamine starburst dendrimers as solubility enhancers. Int J Pharm 197(1-2):239-241
22. Muller S, Schluter AD (2005) Synthesis of water-soluble, multiple functionalizable dendrons for the conversion of large dendrimers or other molecular objects into potential drug carriers. Chemistry 11(19):5589-5610
23. Narayan P (2011) "Overview of drug product development." Curr Protoc Pharmacol Unit 7 3 1-29
24. Neuse E (2005) Macromolecular ferrocene compounds as cancer drug models. J Inorg Organomet Polym Mater 15(1):3-31
25. Ornelas C (2011) Application of ferrocene and its derivatives in cancer research. New J Chem 35(10):1973-1985
26. Qiu LY, Bae YH (2006) Polymer architecture and drug delivery. Pharm Res 23(1):1-30
27. Quirante J, Dubar F et al (2011) Ferrocene-indole hybrids for cancer and malaria therapy. J Organomet Chem 696(5):1011-1017
28. Wang Y, Grayson SM (2012) Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery. Adv Drug Deliv Rev 64(9):852-865
29. Wang Y, Diallo AK et al (2012) Visible-light generation of the naked 12-electron fragment C5H5Fe+: alkyne-to-vinylidene isomerization and synthesis of polynuclear iron vinylidene and alkynyl complexes including hexairon stars. Inorg Chem 51(1):119-127
30. Wu X, Ding B et al (2011) Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy. Int J Nanomed 6:1747-1756
31. Zamboni WC (2008) Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 13(3):248-260
32. Zhang Q, Wang N et al (2012) Poly(amidoamine) dendronized hollow fiber membranes: synthesis, characterization, and preliminary applications as drug delivery devices. Acta Biomater 8(3):1316-1322
33. Zhou J, Atsina KB et al (2012) Novel delivery strategies for glioblastoma. Cancer J 18(1):89-99